BackSpyGlass Pharma Common Stock Overview

SpyGlass Pharma Common Stock Cost of Revenue

Cost of Revenue analysis for SGP.

Quarterly Cost of Revenue

$318000.00

As of Mar 31, 2026

Annual Cost of Revenue (TTM)

N/A

Average Cost of Revenue (Comparison Companies)

Cost of Revenue History

Cost of Revenue Comparison

Annual Cost of Revenue Growth Rate (%)

Annual Cost of Revenue Growth (Absolute)